• SENSEX 76,515.43
    362.57 (+0.48%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
  • Gland Pharma
    2,969.85 3,039.00(%)
  • Power Fin.Corpn.
    357.70 486.45(%)
  • IFCI
    107.45 107.45(%)
  • Shriram Finance
    1,036.40 584.25(%)
  • Tata Technolog.
    796.45 507.50(%)
  • ESDS Software
    895.55 895.55(%)
  • Lenskart Solut.
    694.75 694.75(%)
  • Netweb Technol.
    5,170.00 2,514.75(%)
  • Lumino Inds
    122.00 122.00(%)
  • Kesar India
    1,180.00 1,341.00(%)
  • Multi Comm. Exc.
    3,287.00 3,479.80(%)
  • Tejas Networks
    623.90 644.75(%)
  • RBL Bank
    417.00 417.00(%)
  • ICICI AMC
    2,960.00 2,528.90(%)
  • Polycab India
    8,254.00 6,660.50(%)
  • New India Assura
    234.60 234.60(%)
  • Wockhardt
    2,107.95 2,420.00(%)
  • Angel One
    308.20 360.20(%)
  • Jindal Worldwide
    57.06 57.06(%)
  • Lalithaa Jewel
    308.55 308.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Colinz Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5989.0
  • ISIN : INE923C01011
72.56 1 (1.48%)
  • As on 05 Sep 2026 (EOD)

  • Today’s Low

    72.56

  • Today’s High

    73.65

  • Open

    72.93

  • Perv Close

    71.50

  • 52W Low

    36.11

  • 52W High

    87.91

Key Indicators

  • P/E(TTM)

    17.96

  • Mar.Cap (₹Cr.)

    9.14

  • Div & Yield %

    0.00

  • Book Value(₹)

    69.74

  • Debt-Equity Ratio

    1.48

  • AGM Date

    04-Sep-2026

  • EPS

    4.04

  • P/E Ratio

    17.96

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    9.14

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    1.26

  • BV (₹)

    69.70

  • Sales( ₹ in Cr.)

    6.14

  • NP (in Cr.)

    0.51

  • NP Var(%)

    6.0

  • Div%

    0.0

  • CPS (₹)

    5.30

  • EPS (₹)

    4.10

  • Traded Value (₹ in Lakhs)

    9.14

  • 52 Week High

    87.91

  • 52 Week Low

    36.11

  • Price BSE

    73.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    9.14

  • P/C Ratio

    13.70

  • P/E Ratio

    17.90

  • Price Vs.BV

    4.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 6.14 6.53 7.03 7.15 6.97 6.16
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 6.14 6.53 7.03 7.15 6.97 6.16
Other Income 0.48 0.30 0.28 0.17 0.17 0.19
Stock Adjustments -0.02 -0.08 -0.08 0.03 -0.33 -0.47
Total Income 6.60 6.75 7.23 7.35 6.81 5.88
EXPENDITURE :            
Raw Materials 1.70 2.01 2.23 2.33 1.97 1.72
Power and Fuel Cost 0.14 0.12 0.11 0.11 0.08 0.08
Employee Cost 2.53 2.67 2.79 2.90 2.77 2.39
Other Manufacturing Expenses 0.13 0.10 0.23 0.14 0.14 0.13
Selling and Administration Expenses 1.21 1.05 1.04 1.08 1.03 0.96
Miscellaneous Expenses 0.02 0.01 0.00 0.03 0.06 0.09
Employee Benefit Expenses 2.53 2.67 2.79 2.90 2.77 2.39
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5.72 5.95 6.40 6.58 6.06 5.36
Operating Profit 0.90 0.79 0.82 0.78 0.76 0.53
Interest 0.05 0.04 0.04 0.05 0.08 0.09
Gross Profit 0.85 0.75 0.78 0.73 0.68 0.44
Depreciation 0.16 0.13 0.13 0.13 0.20 0.19
Profit Before Tax 0.69 0.62 0.65 0.60 0.48 0.25
Current Tax 0.19 0.18 0.18 0.16 0.15 0.08
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.02 -0.05 -0.01 -0.02 -0.01 -0.04
Reported Net Profit 0.51 0.50 0.49 0.46 0.34 0.21
Extraordinary Items 0.00 0.01 0.00 -0.02 0.00 0.00
Adjusted Net Profit 0.51 0.49 0.49 0.48 0.34 0.21
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 3.45 2.96 2.47 2.01 1.67 1.47
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 3.97 3.45 2.96 2.47 2.01 1.67
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.04 1.97 1.93 1.82 0.96 0.59
Earnings Per Share(Adj)-Unit Curr 2.04 1.97 1.93 1.82 0.96 0.59
Book Value 39.87 37.61 35.52 32.31 21.69 20.57
Book Value(Adj)-Unit Curr 39.87 37.61 35.52 32.31 21.69 20.57

Shareholding Pattern

  • Promoter Group

    50.60%

  • Public Share Holding

    49.40%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,274,659 50.60 881,159 154
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,274,659 50.60 881,159 154
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 27,194 1.08 21,894 17
Clearing Members 8,954 0.36 8,954 2
Directors of their Relatives 0 0.00 0 0
Employees 3,500 0.14 300 17
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 14,693 0.58 3,993 30
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 26,420 1.05 26,420 35
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 420,440 16.69 420,440 4
Individuals holding nominal share capital up to Rs. 1 lakh 743,240 29.50 497,155 2,915
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,244,441 49.40 979,156 3,020
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 2,519,100 100.00 1,860,315 3,174

Company Background

Colinz Laboratories LtdPharmaceuticals - Indian - Formulations

  • Colinz Laboratories Ltd
  • BSE Code : 5989.0
  • ISIN : INE923C01011

  • Incorporation Year

    1986

  • Registered Office

    A-101 Pratik Industrial Estate
    Mulund Goregaon Link Road, Mumbai,
    Maharashtra-400078

  • Telephone

    91-022-25668002/8003

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Falguni Kumawat

  • Auditor

    Vora & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Colinz Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Colinz Labs 72.56 6.62 6.14 3.27 7.10
Abbott India 26,071.95 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,930.80 2,304.07 2,275.58 102.15 27.86
Glaxosmi. Pharma 2,958.60 3,932.76 3,790.20 47.26 58.17
Novartis India 1,637.10 398.23 356.27 41.34 16.64
Cipla 1,385.00 20,102.60 18,979.95 36.40 13.88
Bliss GVS Pharma 668.70 773.53 729.81 62.09 12.51
Amrutanjan Healt 506.25 520.13 502.55 27.12 24.16
Fermenta Biotec. 498.35 474.15 450.25 23.27 18.77
Guj. Themis Bio. 411.75 152.47 150.80 110.09 27.21
Ambalal Sarabhai 43.72 19.52 3.94 80.96 6.77